THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Apr 29, 2024

Keywords

ClinConnect Summary

The THRIVE Well Cancer study is looking into whether taking a supplement called creatine can help breast cancer survivors improve their strength, endurance, and overall fitness after completing chemotherapy. The researchers want to see how breast cancer survivors respond to exercise compared to healthy women of the same age who have never had cancer. This study is open to women aged 18 to 75 who have recently finished chemotherapy for breast cancer and are willing to join three online exercise sessions each week.

To be eligible, breast cancer survivors must have completed their chemotherapy within the last six months and not have any serious health issues that could prevent them from exercising. Healthy women who have never had cancer can also participate, as long as they meet certain health criteria. Participants can expect to engage in virtual exercise sessions and contribute to important research that may enhance recovery for breast cancer survivors. It’s a great opportunity to stay active while helping advance our understanding of cancer recovery!

Gender

FEMALE

Eligibility criteria

• • Inclusion criteria (Breast Cancer Group)
• • Age 18-75 years of age
• • Diagnosis of breast cancer requiring chemotherapy
• • Recent (within 6 months) completion of chemotherapy
• • Willing to attend 3 virtual-based exercise sessions per week
• • Able to take oral medications
• • Participant is willing and able to provide consent to participating in the study
• • Serum creatinine ≤ 1.5 x ULN or Estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equation.
• • Exclusion criteria (Breast Cancer Group)
• • Physical indications where performing exercise may be limited and/or contraindicated
• • Poorly controlled hypertension (blood pressure \> 160/95mmHg)
• • Current tobacco use (within 6 months)
• • Anabolic steroids use
• • Pitting edema greater than 2+
• • Currently undergoing chemotherapy treatment for cancer
• • History of moderate-severe heart disease (New York Heart Classification greater than grade II) or pulmonary disease (dyspnea on exertion upon climbing one flight of stairs or less; abnormal breath sounds on auscultation)
• • Pregnant or plan to become pregnant during the study
• • Recent (within one month) or anticipated treatment with corticosteroids (except for short term use during the time of chemotherapy), or other appetite stimulants
• • Serum creatinine \> 1.5 x ULN or Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equation
• • Currently taking creatine supplements
• • Lack of availability to a smartphone and/or internet
• • Inclusion Criteria (Healthy Age-matched Control Group)
• • Age 18-75 years of age
• • Have never been diagnosed with cancer
• • Willing to provide consent to participate in this study
• • Exclusion Criteria (Healthy Age-matched Control Group)
• • Physical indications where performing exercise may be limited and/or contraindicated
• • Poorly controlled hypertension (blood pressure \> 160/95mmHg)
• • Current tobacco use (within 6 months)
• • Anabolic steroids use
• • Pitting edema greater than 2+
• • History of cancer diagnosis
• • History of moderate-severe heart disease (New York Heart Classification greater than grade II) or pulmonary disease (dyspnea on exertion upon climbing one flight of stairs or less; abnormal breath sounds on auscultation)
• • Pregnant or currently taking prescribed medication to prepare for pregnancy (i.e.
• • hormonal therapy for IVF)
• • Recent (within one month) treatment with corticosteroids
• • Recent (within one month) use of appetite stimulants or appetite suppressants
• • Serum creatinine \> 1.5 x ULN or Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m2 by Chronic Kidney Disease Epidemiology Collaboration equation
• • Diagnosed Bipolar Disorder or MDQ score indicative of bipolar disorder or Neurological disorders
• • Uncontrolled diabetes (A1c of 6.5% or higher)
• • Currently taking creatine supplements
• • Lack of availability to a smartphone and/or internet